10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
10X Genomics Inc. (TXG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 10,750,345 | $242,742,797 | +16% | 2.22% |
| 2. | Citadel Investment Group Ken Griffin | 2,779,970 | $62,771,723 | +732% | 0.01% |
| 3. | Deerfield Management James E. Flynn | 1,508,943 | $34,071,933 | +153% | 0.5% |
| 4. | Point72 Asset Management Steve Cohen | 1,230,189 | $27,777,660 | 0.07% | |
| 5. | Soleus Capital Guy Levy | 951,000 | $21,473,580 | +33% | 1.66% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.49 | 158 | Officer | 60,046 | 2022-05-13 | Filing | |
| $40.49 | 158 | Officer | 97,523 | 2022-05-13 | Filing | |
| $39.00 | 300,000 | Director | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 300,000 | Director | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 187,500 | Large Shareholder | 187,500 | 2019-09-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.69 | 6,693 | 872,574 | 2024-11-22 | Filing | ||
| $13.69 | 5,807 | 339,897 | 2024-11-22 | Filing | ||
| $22.53 | 6,749 | 882,467 | 2024-08-22 | Filing | ||
| $22.53 | 4,351 | 345,704 | 2024-08-22 | Filing | ||
| $22.53 | 2,961 | 143,242 | 2024-08-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,785,536 | $715,478,620 | 0.05% | |
| 2. | 9,011,332 | $504,274,139 | 0.01% | |
| 3. | 7,919,976 | $443,201,856 | 0.36% | |
| 4. | 5,705,392 | $319,273,759 | 0% | |
| 5. | 4,179,415 | $233,880,121 | 0.02% |
News See All
10x Genomics, Inc. (NASDAQ:TXG) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Mark, and I will be your conference operator today.
10x Genomics, Inc. (NASDAQ:TXG) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kayla and I will be your conference operator today.
10 Stocks That Will Skyrocket
The primary lure of investing, as you're likely to know, is to make money. Every day thousands of investors pour into the market to pick out what they believe will be winners to make them rich.
Does 10x Genomics (TXG) Have a Strong Growth Opportunity Ahead?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2024 investor letter.
10x Genomics, Inc. (NASDAQ:TXG) Q1 2024 Earnings Call Transcript
Operator: Good day everyone and welcome to the 10x Genomics First Quarter 2024 Earnings Call. Today's call is being recorded.
11 Oversold MidCap Stocks To Buy Now
In this piece, we will take a look at the 11 oversold midcap stocks to buy now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
10x Genomics, Inc. (NASDAQ:TXG) Q4 2023 Earnings Call Transcript
10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.36. 10x Genomics, Inc.
12 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the 12 best genomics stocks to buy now.
Billionaire Hedge Funds
